FdaApplication
NDA 212782
Identifiers
- fda_app_no: NDA212782
Properties
| Property | Value |
|---|---|
| applicant_name | SHILPA MEDICARE LTD |
| application_type | NDA |
| approval_date | 2024-08-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BORTEZOMIB | BORTEZOMIB | 3.5MG/1.4ML (2.5MG/ML) | SOLUTION;INTRAVENOUS, SUBCUTANEOUS |
1 product